Literature DB >> 22175894

Myxoid leiomyosarcoma of the uterus.

David M Burch1, Fattaneh A Tavassoli.   

Abstract

AIMS: Recent guidelines have suggested the presence of tumour cell necrosis (TCN), atypia and mitotic index as major features in the distinction of myxoid leiomyosarcomas (MLMSs) from myxoid leiomyomas. The aim of this study was to focus on an invasive growth pattern as a significant feature in this distinction in the absence of TCN. METHODS AND
RESULTS: Twelve uterine smooth muscle tumours with myxoid change in ≥60% of the lesion were interpreted as MLMS on the basis of the presence of focal mild atypia as well as one or more of the following features: (i) infiltrative growth pattern; (ii) vascular invasion; (iii) mitotic index of ≥5 mitotic figures (m.f.)/50 high-power fields (HPFs); and (iv) a combination of at least focal severe atypia and at least 2-4 m.f./50 HPFs. Unequivocal TCN was not evident in any of these tumours. The various morphological features were correlated with outcome. With follow-ups ranging from 19 to 113 months (mean 60 months), five of the 12 women developed recurrences, and two of them died. Nine of the 12 tumours had an infiltrative growth pattern, and all five recurrent tumours were from this group.
CONCLUSION: In the absence of TCN, an infiltrative margin is a major factor related to the potential for aggressive behaviour of MLMS.
© 2011 Blackwell Publishing Limited.

Entities:  

Mesh:

Year:  2011        PMID: 22175894     DOI: 10.1111/j.1365-2559.2011.04053.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  9 in total

Review 1.  Practical issues in uterine pathology from banal to bewildering: the remarkable spectrum of smooth muscle neoplasia.

Authors:  Esther Oliva
Journal:  Mod Pathol       Date:  2016-01       Impact factor: 7.842

2.  A rare case of uterine myxoid leiomyosarcoma: a case report.

Authors:  Luminita Elena Mitrache; Vasile Adrian Dumitru; George Simion; Monica Cirstoiu; Maria Sajin
Journal:  Maedica (Buchar)       Date:  2014-09

Review 3.  [Current WHO classification of the female genitals : Many new things, but also some old].

Authors:  Doris Mayr; Elisa Schmoeckel; Anne Kathrin Höhn; Grit Gesine Ruth Hiller; Lars-Christian Horn
Journal:  Pathologe       Date:  2021-04-06       Impact factor: 1.011

Review 4.  Uterine myxoid leiomyosarcoma - a rare malignant tumor: the role of complex morphopathological assay. Review and case presentation.

Authors:  Anca Maria Istrate-Ofiţeru; George Lucian Zorilă; Dan Ruican; Ana Maria Petrescu; Elena Iuliana Anamaria Berbecaru; Gabriela Camelia Roşu; Răzvan Grigoraş Căpitănescu; Rodica Daniela Nagy; Liliana Cercelaru; Antonie Edu; Dominic Gabriel Iliescu; Roxana Cristina Drăguşin
Journal:  Rom J Morphol Embryol       Date:  2021 Oct-Dec       Impact factor: 0.833

5.  Novel PLAG1 Gene Rearrangement Distinguishes a Subset of Uterine Myxoid Leiomyosarcoma From Other Uterine Myxoid Mesenchymal Tumors.

Authors:  Javier A Arias-Stella; Ryma Benayed; Esther Oliva; Robert H Young; Lien N Hoang; Cheng-Han Lee; Achim A Jungbluth; Denise Frosina; Robert A Soslow; Cristina R Antonescu; Marc Ladanyi; Sarah Chiang
Journal:  Am J Surg Pathol       Date:  2019-03       Impact factor: 6.298

6.  Myxoid leiomyosarcoma of the uterus with mature adipocytes and numerous bizarre multinucleated giant cells.

Authors:  Masayuki Shintaku; Takahito Ashihara; Takashi Koyama
Journal:  Pathol Int       Date:  2015-01-13       Impact factor: 2.534

7.  Debulking surgery and hyperthermic intraperitoneal chemotherapy in the management of a recurrent aggressive uterine myxoid leiomyosarcoma with peritoneal dissemination.

Authors:  Daisuke Inoue; Makoto Yamamoto; Genki Sugita; Tetsuji Kurokawa; Yoshio Yoshida
Journal:  Gynecol Oncol Rep       Date:  2015-07-02

8.  Uterine myxoid leiomyosarcoma with tumor embolism extending into the right atrium.

Authors:  Hiromi Imai; Hiroshi Yagi; Kaoru Okugawa; Hironori Kenjo; Tatsuhiro Ohgami; Yoshiaki Kawano; Eisuke Kaneki; Akimasa Ichinoe; Kazuo Asanoma; Hideaki Yahata; Kenzo Sonoda; Hiroaki Kobayashi; Tsunehisa Kaku; Kiyoko Kato
Journal:  Case Rep Obstet Gynecol       Date:  2015-02-02

9.  Long-lasting activity of trabectedin in refractory uterine leiomyosarcoma: a case report.

Authors:  Alberto Bongiovanni; Nada Riva; Marianna Ricci; Laura Mercatali; Chiara Liverani; Federico La Manna; Alessandro De Vita; Davide Cavaliere; Federica Pieri; Devil Oboldi; Giorgio Maria Verdecchia; Dino Amadori; Toni Ibrahim
Journal:  BMC Cancer       Date:  2015-12-22       Impact factor: 4.430

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.